Literature DB >> 1585937

Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL).

.   

Abstract

Data from 659 patients with a diagnosis of lupus nephritis were retrospectively collected among 32 nephrology centers in Italy, as a result of the collaborative effort of the Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL, Italian Lupus Nephritis Study Group). The overall probability of renal survival was 80% 10 years after the diagnosis. The probability of maintaining life-supporting renal function was evaluated according to several variables (clinical characteristics at presentation, World Health Organization [WHO] histologic classification). The presence at the time of diagnosis of hypertension and diffuse proliferative nephritis (WHO class IV) was associated with a worse prognosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1585937     DOI: 10.1016/s0272-6386(12)80957-7

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  18 in total

1.  Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus.

Authors:  Rina Mina; Emily von Scheven; Stacy P Ardoin; B Anne Eberhard; Marilynn Punaro; Norman Ilowite; Joyce Hsu; Marisa Klein-Gitelman; L Nandini Moorthy; Eyal Muscal; Suhas M Radhakrishna; Linda Wagner-Weiner; Matthew Adams; Peter Blier; Lenore Buckley; Elizabeth Chalom; Gaëlle Chédeville; Andrew Eichenfield; Natalya Fish; Michael Henrickson; Aimee O Hersh; Roger Hollister; Olcay Jones; Lawrence Jung; Deborah Levy; Jorge Lopez-Benitez; Deborah McCurdy; Paivi M Miettunen; Ana I Quintero-del Rio; Deborah Rothman; Ornella Rullo; Natasha Ruth; Laura E Schanberg; Earl Silverman; Nora G Singer; Jennifer Soep; Reema Syed; Larry B Vogler; Ali Yalcindag; Cagri Yildirim-Toruner; Carol A Wallace; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-03       Impact factor: 4.794

2.  Histopathological indicators of disease outcome in class IV lupus nephritis: a revisit of various indices.

Authors:  Manish Rathi; Krishan Lal Gupta; Kusum Joshi; Pramod K Gupta; Aman Sharma; Harbir Singh Kohli; Vivekanand Jha; Vinay Sakhuja
Journal:  Rheumatol Int       Date:  2015-03-11       Impact factor: 2.631

3.  Characteristics and influence factors of pathologic transformation in the subclasses of class IV lupus nephritis.

Authors:  Jian-jun Gao; Guang-yan Cai; Shu-wen Liu; Li Tang; Xue-guang Zhang; Yang Yang; Pu Chen; Shu-xin Liu; Jia-yao Ji; Suo-zhu Shi; Zhong Yin; Xiang-mei Chen
Journal:  Rheumatol Int       Date:  2011-03-26       Impact factor: 2.631

Review 4.  Prognosis in systemic lupus erythematosus.

Authors:  J M Esdaile
Journal:  Springer Semin Immunopathol       Date:  1994

Review 5.  Treatment of proliferative lupus nephritis: a slowly changing landscape.

Authors:  Vladimir Tesar; Zdenka Hruskova
Journal:  Nat Rev Nephrol       Date:  2010-12-21       Impact factor: 28.314

6.  A retrospective analysis of clinical presentation of lupus nephritis.

Authors:  Sandeep Singh; Xin J Zhou; Chul Ahn; Ramesh Saxena
Journal:  Am J Med Sci       Date:  2011-12       Impact factor: 2.378

7.  Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy.

Authors:  Howard A Austin; Gabor G Illei; Michelle J Braun; James E Balow
Journal:  J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 10.121

8.  [Lupusnephritis].

Authors:  M Haubitz
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

9.  Presentation and outcome of paediatric membranous non-proliferative lupus nephritis.

Authors:  Boris Hugle; Earl D Silverman; Pascal N Tyrrell; Elizabeth A Harvey; Diane Hébert; Susanne M Benseler
Journal:  Pediatr Nephrol       Date:  2014-07-31       Impact factor: 3.714

10.  Short-interval lower-dose intravenous cyclophosphamide as induction and maintenance therapy for lupus nephritis: a prospective observational study.

Authors:  X W Zhang; Chun Li; X X Ma; J X Zhao; Yuan An; Shuang Liu; Yan Li; Z G Li
Journal:  Clin Rheumatol       Date:  2014-04-18       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.